ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.508,67
1,09%
S&P 500
5.127,79
1,26%
US Dollar vs BRL
5,10129
0,57%
Bitcoin
64.475,86
0,74%
Brent Oil
83,115
-0,01%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Myriad Genetics Inc (MYGN)

  7. Myriad Genetics Inc (MYGN) Notícias

MYGN Myriad Genetics Inc

19,43
0,21 (1,09%)
03 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Myriad Genetics Inc MYGN NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
Upgrade Icon
0,21 1,09% 19,43 18:58:41
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
19,85 19,40 20,09 19,47 19,22
mais cotações »

Notícias Recentes

Data Hora Fonte Título
30/04/202417:05GLOBEMyriad Genetics to Release First Quarter 2024 Financial..
17/04/202409:00GLOBENearly Half of Americans Say They’ve Lost Time in Their..
16/04/202410:15GLOBENew Myriad Genetics Study Published in Prenatal Diagnosis..
09/04/202409:00GLOBEMyriad Genetics Research Shows Reduction in Hospitalizations..
21/03/202422:40GLOBEMyriad Genetics Announces Foundational Patent Granted for..
20/03/202417:05GLOBEMyriad Genetics Announces Patent Granted for SneakPeek® Snap..
27/02/202418:05GLOBEMyriad Genetics Reports Strong Fourth Quarter and Full-Year..
27/02/202411:15GLOBEMyriad Genetics and National Cancer Center Hospital East in..
21/02/202418:05GLOBEMyriad Genetics to Release Fourth Quarter and Full Year 2023..
15/02/202418:05GLOBEMyriad Genetics Appoints Dallas Reed, MD, FACOG, FACMG as..
01/02/202411:25GLOBEMyriad Genetics Completes Acquisition of Precise Tumor,..
30/01/202419:00GLOBEMyriad Genetics Names George Daneker Jr., MD, as President..
18/01/202420:10GLOBEMyriad Genetics to Acquire Precise Tumor, Precise Liquid and..
09/01/202418:05GLOBEMyriad Genetics Applauds New Germline Testing Guideline for..
03/01/202418:05GLOBEMyriad Genetics to Present at 42nd Annual J.P. Morgan..
21/12/202310:30GLOBEMyriad Genetics Chief Financial Officer Bryan Riggsbee..
20/12/202310:00GLOBEMyriad Genetics Establishes Comprehensive Pan-Cancer..
20/11/202318:05GLOBEMyriad Genetics Celebrates One Million SneakPeek® Results..
16/11/202318:05GLOBEMyriad Genetics and Personalis Partner to Market..
09/11/202309:00GLOBEMyriad Genetics to Participate in Stephens Annual Investment..
08/11/202323:20GLOBEMyriad Genetics Announces Pricing of Upsized Offering of..
08/11/202318:10GLOBEMyriad Genetics Announces Proposed Offering of $100 Million..
06/11/202318:05GLOBEMyriad Genetics Reports Third Quarter 2023 Financial..
01/11/202310:00GLOBEMyriad Genetics Appoints Sam Raha as Chief Operating Officer
31/10/202317:05GLOBEMyriad Genetics to Release Third Quarter Financial Results..
26/10/202309:00GLOBEQIAGEN and Myriad Genetics partner to advance companion..
28/09/202317:59PRNUSBREAST CANCER AWARENESS MONTH: NEW CANCER RISK SURVEY..
28/09/202308:00GLOBENew Myriad Genetics Survey Shows Breast Cancer Risk Factors..
19/09/202310:00GLOBEMyriad Genetics and Illumina Achieve Milestones in Strategic..
19/09/202308:00GLOBEMyriad Genetics Issues 2022 Environmental, Social and..
18/09/202309:00GLOBEMyriad Genetics and Leading Cancer Center Collaborate to..
06/09/202317:05GLOBEMyriad Genetics Named to 2023 Best Workplaces in Health Care..
06/09/202308:00GLOBENew Myriad Genetics Survey Reveals Widespread Confusion and..
05/09/202309:00GLOBEMyriad Genetics to Participate in Morgan Stanley Global..
22/08/202310:00GLOBEMyriad Genetics and Onsite Women’s Health Partner to Help..
17/08/202317:05GLOBEMyriad Genetics to Host Investor Day on September 19, 2023
15/08/202308:05GLOBEMyriad Genetics Advances Prostate Cancer Care with Addition..
08/08/202317:05GLOBEMyriad Genetics and Intermountain Health Participate in..
07/08/202317:05GLOBEMyriad Genetics Announces Enhancements to the GeneSight®..
03/08/202317:05GLOBEMyriad Genetics Reports Second Quarter 2023 Financial..
27/07/202317:05GLOBEMyriad Genetics to Release Second Quarter Financial Results..
24/07/202309:00GLOBEMyriad Genetics Announces Inclusion of Breast Density to..
06/07/202309:30GLOBEMyriad Genetics Announces New $90 Million Asset-Based Credit..
12/06/202309:00GLOBEMyriad Genetics Announces Research Collaboration to use..
07/06/202317:05GLOBEMyriad Genetics to Participate in Goldman Sachs Healthcare..
01/06/202309:00GLOBEMyriad Genetics Highlights Latest Oncology Portfolio..
31/05/202309:00GLOBEAdam Brufsky, MD, PhD, FACP Named Oncology Scientific..
24/05/202317:05GLOBEMyriad Genetics Adds Folate Receptor Alpha to Precise™..
08/05/202317:05GLOBEMyriad Genetics Earns 2023 Great Place to Work..

Seu Histórico Recente

NASDAQ
MYGN
Myriad Genetics
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados